FAM
PRME icon

Fred Alger Management’s Prime Medicine PRME Stock Holding History

Fred Alger Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-122,654
Closed -$680K – 502
2025
Q3 		$680K Sell
122,654
-260,540
-68% -$1.06M ﹤0.01% 385
2025
Q2 		$946K Buy
+383,194
New +$591K ﹤0.01% 359

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Fred Alger Management's PRME Position: Q4 2025 in Review

Fred Alger Management sold out of Prime Medicine (PRME) in Q4 2025, closing a stake of 122,654 shares — an estimated $680K sold.

Fred Alger Management first reported a position in PRME in Q2 2025 and held it in 2 quarters. The position peaked at $946K in Q2 2025. 183 funds tracked by Wall St. Rank hold PRME as of Q4 2025.

  • Fred Alger Management reported no remaining Prime Medicine position as of Q4 2025 after selling out during the quarter.
  • Fred Alger Management sold 122,654 Prime Medicine shares in Q4 2025, an estimated $680K.
  • Fred Alger Management first reported a position in Prime Medicine in Q2 2025 and held it in 2 quarters.
  • Fred Alger Management's Prime Medicine position peaked at $946K in Q2 2025.
  • 183 funds tracked by Wall St. Rank held Prime Medicine as of Q4 2025.

Based on Fred Alger Management's 13F filing for Q4 2025, filed 17 Feb 2026.